SEC Form 5 · accession 0001144204-16-082902
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Pruzanski
Officer — CEO & President · Director
Period of report
Dec 28, 2015
Accepted (ET)
Feb 16, 2016 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2015 | G | 3,900 | $0.00 | D | 548,956 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person made a gift to a 501(c)(3) charitable foundation.